|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| General and administrative | |||||
| Professional fees | |||||
| Research and development | |||||
| Sales and marketing | |||||
| Impairment | |||||
| Asset Impairment Charges | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest expense | |||||
| Other income (expense): | |||||
| Interest expense | |||||
| Loss on debt extinguishment | |||||
| Loss on equity financing | |||||
| Gain on change in fair value of warrant liabilities | |||||
| Gain (loss) on disposal of fixed assets | |||||
| Other expense, net | |||||
| Other income (expense), net | |||||
| Total other income (expense), net | |||||
| Net loss before provision for income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Accrued dividends on Series F Preferred Stock | |||||
| Deemed dividends on Series F Preferred Stock | |||||
| Deemed dividends on Series F Preferred Stock and Warrants | |||||
| Amortization of unrecognized periodic pension costs | |||||
| Foreign currency cumulative translation adjustment | |||||
| Total comprehensive loss, net of tax | |||||
| Accrued dividends on Series F Preferred Stock | |||||
| Deemed dividends on Series F and G Preferred Stock and Warrants | |||||
| Net loss attributable to common stockholders | |||||
| Net loss per common share - Basic and Diluted (in dollars per share) | |||||
| Weighted average number of shares outstanding during the period — Basic and Diluted (in shares) | |||||
| Comprehensive loss: | |||||
| Amortization of unrecognized periodic pension costs | |||||
| Foreign currency cumulative translation adjustment | |||||
| Total comprehensive loss, net of tax | |||||
Loading...